<DOC>
	<DOCNO>NCT02303418</DOCNO>
	<brief_summary>The study aim compare role carbetocin oxytocin prevention atonic PPH woman undergo CS placenta previa . 200 woman randomly divide 2 equal group use computer generate random number , Group 1 receive Carbetocin 100 µgm ( Pabal® Ferring , UK ) group 2 receive oxytocin 5IU ( Syntocinon® , Novartis , Switzerland ) .</brief_summary>
	<brief_title>Carbetocin Versus Oxytocin Prevention Post Partum Haemorrhage ( PPH ) Women Undergoing Caesarean Sections Placenta Previa : A Randomised Controlled Trial</brief_title>
	<detailed_description>Obstetric haemorrhage remain one major cause maternal death develop develop country . Postpartum haemorrhage ( PPH ) define blood loss &gt; 500 ml blood genital tract within 24 hour birth baby . PPH minor ( 500-1000 ml ) major ( 1000 ml ) . The frequent cause PPH uterine atony , contribute 80 % PPH case . Risk factor atonic PPH include multiple pregnancy , placenta previa , previous PPH , body mass index ( BMI ) &gt; 30 , prolong labour , fetal macrosomia &gt; 4kg primipara &gt; 40 year . Placenta praevia exist placenta insert wholly part lower segment uterus . It classify ultrasound image accord relevant clinically : placenta lie internal cervical o , consider major praevia ; lead edge placenta low uterine segment cover cervical o , minor partial praevia exists . Oxytocin currently uterotonic first choice . It proven decrease incidence PPH 40 % rapid onset action good safety profile . A disadvantage oxytocin short half-life 4-10 min , regularly require continuous intravenous infusion repeat intramuscular injection . Carbetocin long-acting oxytocin analogue indicate prevention uterine atony child birth cesarean section ( CS ) epidural spinal anaesthesia . Carbetocin rapid onset action ( within 1-2 min ) prolong duration action ( approximately 1 h ) sustain uterine response contraction higher amplitude frequency . Its safety profile comparable oxytocin . The study conduct Cairo university hospital BeniSuef university hospital . All patient placenta previa covering , less 2cm internal cervical o approach antenatal clinic . Women invite participate study , invitation include clear full explanation study . Only patient sign informed write consent participate study . The exclusion criterion gestational age &lt; 37 week , hypertension , preeclampsia , cardiac , renal liver disease , epilepsy , need general anaesthesia , know hypersensitivity carbetocin suspect placenta accreta . 200 woman randomly divide 2 equal group use computer generate random number , Group 1 receive Carbetocin 100 µgm ( Pabal® Ferring , UK ) group 2 receive oxytocin 5IU ( Syntocinon® , Novartis , Switzerland ) . Both drug dilute 10ml saline give anaesthetist slowly intravenously delivery baby . The investigator include control group ethical reason . The CS do presence consultant Obstetrician consultant anaesthetist , cross-matched blood ready level 2 critical care bed available . CS do low uterine segment , placenta encounter , push aside baby deliver . The allocated drug dilute 10ml saline give anesthesist slowly intravenously delivery baby . The uterine tone amount bleed note need uterotonic agent determine 2 minute give drug . Blood loss estimate weigh swab , use pictorial chart estimate amount blood suction container . Blood haemoglobin assess 24 hour CS .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Placenta Previa</mesh_term>
	<mesh_term>Carbetocin</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Women undergo CS placenta previa Gestational age &lt; 37 week Hypertension Preeclampsia Cardiac , renal liver disease Need general anaesthesia Known hypersensitivity carbetocin Suspected placenta accreta</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Obstetrics</keyword>
</DOC>